MABA members get free access to use for due diligence related to startups pitching to MABA.
Other partnerships
Leo Pharma
While most tools track clinical trials, we’re collaborating with LEO Pharma to bring earlier visibility into emerging assets - uniting signals scattered accross sources, from very early preclinical stages onwards, and for all therapeutic areas, so promising science reaches patients faster.
OBN distributes our solution to their members via referral and marketing activities (webinar, newsletter, live event) and get a discount+kicker for any subscription.